Experts Warn of Yaz Blood Clot Risks As Bayer Offers Settlements

Share Article

The Web’s largest source for information on Yaz research, side effects and legal news. Visit http://www.YazLawsuit.com

yaz lawsuit
Anyone who took Yaz or Yasmin and suffered a blood clot, DVT, stroke or Pulmonary Embolism is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.

The Yaz Resource Center, a patient advocacy group, is alerting women who have taken the birth control drugs Yaz or Yasmin that experts have linked them to an increased risk of blood clots. The maker of the drugs, Bayer, has announced additional funding to resolve claims by those injured. However, the time to file a claim is limited.

Anyone who took Yaz or Yasmin and suffered a blood clot, DVT, stroke or Pulmonary Embolism is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.

On October 25, 2011, the British Medical Journal published a study from researchers at The University of Copenhagen which related the hormone in Yaz to blood clots.

The FDA followed on October 27, 2011, releasing its own study of more than 800,000 women titled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" which found drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.

On April 10, 2012, the FDA announced it would require additional label warnings for drugs like Yaz which contain the chemical drospirenone, cautioning that the chemical may be associated with a higher risk for blood clots.

According to Bloomberg on April 13, 2012, Yaz is still the fourth most popular oral contraceptive. However, a QuarterWatch report from the Institute for Safe Medicine Practices on May 31, 2012 which ranked Yaz and Yasmin as the second-worst drugs in 2011 for the number of complications reported to the FDA.

Due to the large number of Yaz lawsuits filed by patients, a federal panel established a Multi-District Litigation court in Illinois to handle the claims. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100). The court estimates more than 10,000 patients have filed a claim so far.

Bloomberg News reported on July 31st that Bayer has settled nearly 1900 Yaz lawsuits so far for more than $400 million, at an average of around $212,000. The article also indicates Bayer has more than doubled its reserves for settling these cases to over $610 million, which could be positive news for those injured who have yet to file a claim.

Anyone affected by blood clots, stroke, DVT or pulmonary embolism after taking Yaz should learn their legal rights as soon as possible and find out if a yaz lawsuit is an option.

The Yaz Resource Center cautions that only certain cases may be eligible for a Yaz settlement. Victims should make sure they choose a lawyer with experience in defective drug litigation. The Resource Center only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on research, side effects and litigation news related to the drug Yaz, or to speak with a lawyer, visit http://www.YazLawsuit.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Schroeder
Visit website